Literature DB >> 184920

Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes.

N S Scher, F Quagliata, V G Malathi, D Faig, R A Melton, R Silber.   

Abstract

The specific activity of cyclic adenosine 3':5'-monophosphate phosphodiesterase was measured in lymphocytes isolated from the blood of normal subjects, from patients with chronic lymphocytic leukemia, and from tonsil tissue. The mean specific activity of cyclic adenosine 3':5'-monophosphate phosphodiesterase in the lymphocytes from patients with untreated chronic lymphocytic leukemia was lower than that in lymphocytes from the blood of normal subjects or from tonsils. Cyclic adenosine 3':5'-monophosphate phosphodiesterase levels did not correlate with differences in B- and T-cell lymphocyte subpopulations or with peripheral blood lymphocyte counts.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184920

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia.

Authors:  J Mendelsohn; J Nordberg
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

2.  Increased ascorbic acid content in chronic lymphocytic leukemia B lymphocytes.

Authors:  L Liebes; R Krigel; S Kuo; D Nevrla; E Pelle; R Silber
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

3.  Patterns of cyclic nucleotides in normal and leukaemic human leucocytes.

Authors:  M Peracchi; A T Maiolo; L Lombardi; F B Catena; E E Polli
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.